ReShape Lifesciences announces $750k offering with Series D preferred and warrant repricing

Vyome Holdings, Inc

Gross proceeds $750k from sale of 2.39M shares, 2,500 Series D preferred, and pre-funded warrants at $0.26/share.
Common warrants to purchase 2.88M shares at $0.30, exercisable after 6 months, expire 5.5 years.
Existing warrants for 5.35M shares amended: exercise price cut to $0.30, non-exercisable for 6 months, extended expiry.
Company to seek shareholder approval for reverse split and increase authorized shares from 100M to 300M.

item 1.01 item 3.02 item 3.03 item 5.03 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Vyome Holdings, Inc entered into Securities Purchase Agreement valued at $750,000 (effective 2022-11-08).

Action: entry
Agreement: equity purchase
Value: $750,000
Effective: 2022-11-08

Exact text from the filing

On November 8, 2022, ReShape Lifesciences Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a certain institutional investor (the “Investor”), pursuant to which the Company agreed to issue and sell to the Investor in a registered direct offering (the “Registered Offering”) (i) 2,392,524 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), (ii) 2,500 shares of the Company’s Series D Mirroring Preferred Stock, par value $0.001 per share and stated value of $0.001 per share (the “Preferred Stock”), and (iii) pre-funded warrants to purchase an aggregate of 492,091 shares of Common Stock (the “Pre-funded Warrants”).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Vyome Holdings, Inc amended Warrant Amendment Agreement.

Action: amendment

Exact text from the filing

In connection with the Offering, the Company also entered into a warrant amendment agreement (the “Warrant Amendment Agreement”) with the Investor.

View on SEC.gov

Browse all material agreements →

Vyome Holdings, Inc filing history →

Source: SEC EDGAR

accession 0001104659-22-117515

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.